Works matching DE "IFOSFAMIDE"


Results: 372
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Ifosfamide nephrotoxicity in adult patients.

    Published in:
    Clinical Kidney Journal, 2020, v. 13, n. 4, p. 660, doi. 10.1093/ckj/sfz183
    By:
    • Ensergueix, Gaël;
    • Pallet, Nicolas;
    • Joly, Dominique;
    • Levi, Charlène;
    • Chauvet, Sophie;
    • Trivin, Claire;
    • Augusto, Jean-Francois;
    • Boudet, Rémi;
    • Aboudagga, Hail;
    • Touchard, Guy;
    • Nochy, Dominique;
    • Essig, Marie;
    • Thervet, Eric;
    • Lazareth, Hélène;
    • Karras, Alexandre
    Publication type:
    Article
    26

    The growing pains of ifosfamide.

    Published in:
    Clinical Kidney Journal, 2020, v. 13, n. 4, p. 500, doi. 10.1093/ckj/sfaa017
    By:
    • Sprangers, Ben;
    • Lapman, Sebastian
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Partial Fanconi syndrome induced by ifosfamide.

    Published in:
    Baylor University Medical Center Proceedings, 2019, v. 32, n. 1, p. 73, doi. 10.1080/08998280.2018.1536020
    By:
    • Panezai, Muhammad Ajmal;
    • Owen, Charles;
    • Szerlip, Harold M.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).

    Published in:
    Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_322
    By:
    • Fornecker, L.;
    • Delwail, V.;
    • Thieblemont, C.;
    • Ghesquieres, H.;
    • Bouabdallah, K.;
    • Tilly, H.;
    • Le Calloch, R.;
    • Morschhauser, F.;
    • Costello, R.;
    • Slama, B.;
    • Gyan, E.;
    • Chauchet, A.;
    • Ngirabacu, M.;
    • Durot, E.;
    • Choquet, S.;
    • Capdupuy, C.;
    • Le Goff, M.;
    • Voillat, L.;
    • Snauwaert, S.;
    • Amorim, S.
    Publication type:
    Article
    43
    44
    45
    46

    Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5479, doi. 10.1007/s00432-022-04454-8
    By:
    • Rodriguez-Cid, Jeronimo Rafael;
    • Juarez-Vignon Whaley, Juan Jose;
    • Sánchez-Domínguez, Gisela;
    • Guzmán-Casta, Jordi;
    • Carrasco-CaraChards, Sonia;
    • Guzmán-Huesca, Jorge;
    • Riera-Sala, Rodrigo;
    • Sánchez-Ríos, Carla Paola;
    • Cruz-Zermeño, Mayte;
    • Seidman-Sorsby, Alec;
    • de Jesús Rodríguez-Zea, Ivan;
    • Alatorre-Alexander, Jorge Arturo;
    • Martínez-Barrera, Luis Manuel;
    • Santillán-Doherty, Patricio Javier;
    • Godina-Flores, Aminadab;
    • Imaz-Olguin, Victoria;
    • Sosa-Sánchez, Ricardo;
    • Green-Renner, Dan
    Publication type:
    Article
    47
    48
    49
    50